pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
plogosertib
plogosertib [INN]
Bladder Cancer
Tethra Biosciences Inc
0 catalysts
Phase 2
pocenbrodib hydrochloride
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Pathos AI Inc
0 catalysts
Phase 2
podentamig
podentamig [INN]
Refractory Multiple Myeloma
$MRKMerck & Co., Inc.
0 catalysts
Phase 2
← prev
page 55 of 62
next →
131
Pain89
Neurology1
polzastobart
Cutaneous Squamous Cell Carcinoma (cSCC)
Concentra Biosciences LLC
0 catalysts
Marketed
ponatinib hydrochloride
Iclusig (ponatinib hydrochloride)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Bcr/Abl fusion protein
$TAKTAKEDA PHARMACEUTICAL CO LTD
0 catalysts
Marketed
porfimer sodium
Photofrin (porfimer sodium)
Endobronchial Cancer
Concordia Healthcare USA Inc
0 catalysts
Phase 1
potrasertib
potrasertib [INN]
Solid Tumor
IMPACT Therapeutics Inc
0 catalysts
Marketed
pralatrexate
Folotyn (pralatrexate)
Peripheral T-Cell Lymphomas (PTCL)
Fresenius Kabi USA LLC
0 catalysts
Marketed
pralsetinib
Gavreto (pralsetinib [INN])
Solid Tumor
Blueprint Medicines Corp
0 catalysts
Marketed
prednisolone
Prednisolone (prednisolone [INN])
Allergic Conjunctivitis
Teva Pharmaceuticals USA Inc
0 catalysts
Marketed
prednisolone sodium phosphate
Prednisolone Sodium Phosphate (prednisolone sodium phosphate)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Mission Pharmacal Co
0 catalysts
Marketed
prednisone
Prednisone (prednisone [INN])
Aspiration Pneumonitis
Vintage Pharmaceuticals Inc (Inactive)
0 catalysts
Phase 2
prexasertib mesylate monohydrate
Endometrial Cancer
$ACRVAcrivon Therapeutics, Inc.
0 catalysts
Phase 2
prexigebersen
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Growth factor receptor-bound protein 2 mRNA
$BPTHBIO-PATH HOLDINGS, INC.
0 catalysts
Phase 1
pritumumab
pritumumab [INN]
Anaplastic Astrocytoma
Nascent Biotech Inc
0 catalysts
Phase 2
prizloncabtagene autoleucel
prizloncabtagene autoleucel [INN]
Diffuse Large B-Cell Lymphoma
Janssen Biotech Inc
0 catalysts
Marketed
procarbazine hydrochloride
Matulane (procarbazine hydrochloride)
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma)
Leadiant Biosciences Inc
0 catalysts
Phase 1
prulacabtagene leucel
B-Cell Non-Hodgkin Lymphoma
$ACETAdicet Bio, Inc.
0 catalysts
Phase 3
pumitamig
pumitamig [INN]
Non-Small Cell Lung Cancer
$BNTXBioNTech SE
0 catalysts
Phase 2
quaratusugene ozeplasmid
Reqorsa (quaratusugene ozeplasmid)
Non-Small Cell Lung Cancer
$GNPXGenprex, Inc.
0 catalysts
Phase 3
quemliclustat
Pancreatic Ductal Adenocarcinoma
$RCUSArcus Biosciences, Inc.
0 catalysts
Phase 2
radgocitabine
radgocitabine [INN]
Refractory Acute Myeloid Leukemia
Delta-Fly Pharma Inc
0 catalysts
Marketed
radium Ra 223 dichloride
Xofigo (radium Ra 223 dichloride)
Bone Metastasis
Bayer HealthCare Pharmaceuticals Inc
0 catalysts
Phase 1
ragistomig
ragistomig [INN]
Esophageal Cancer
$NBPNovaBridge Biosciences
0 catalysts
Marketed
raloxifene hydrochloride
Raloxifene Hydrochloride (raloxifene hydrochloride)
Post Menopausal Osteoporosis
Modavar Pharmaceuticals LLC
0 catalysts
Phase 3
ramucirumab
Cyramza (ramucirumab)
Adenocarcinoma Of The Gastroesophageal Junction
Vascular endothelial growth factor receptor 2
Eli Lilly and Co
0 catalysts
Marketed
ranitidine hydrochloride
Ranitidine Hydrochloride (ranitidine hydrochloride)
Systemic Mastocytosis
VKT Pharma Pvt Ltd
0 catalysts
Phase 1
ratangratinib
ratangratinib [INN]
Bile Duct Cancer (Cholangiocarcinoma)
3D Medicines Inc
0 catalysts
Preclinical
redaporfin
redaporfin [INN]
Bile Duct Cancer (Cholangiocarcinoma)
Luzitin SA
0 catalysts
Marketed
regorafenib
Stivarga (regorafenib)
Recurrent Glioblastoma Multiforme (GBM)
Discoidin domain-containing receptor 2Ephrin type-A receptor 2
Bayer AG
0 catalysts